Dopamine agonist monotherapy in early Parkinson's disease

被引：1

作者：

Clarke, CE ^{[1
]}

机构：

[1] City Hosp, Dept Neurol, Birmingham B18 7QH, W Midlands, England

[2] Univ Birmingham, Birmingham B18 7QH, W Midlands, England

来源：

HOSPITAL MEDICINE | 2003年 / 64卷 / 01期

关键词：

D O I：

10.12968/hosp.2003.64.1.1836

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

While levodopa therapy for Parkinson's disease is still considered the gold standard, motor complications are significant disadvantages of treatment. Monotherapy with dopamine agonists may present an alternative approach with a reduced likelihood of developing dyskinesias. Further studies are required before a definitive judgment can be made.

引用

页码：8 / 11

页数：4

共 13 条

[1] Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease [J].

Allain, H ;

Destée, A ;

Petit, H ;

Patay, M ;

Schück, S ;

Bentué-Ferrer, D ;

Le Cavorzin, P .

EUROPEAN NEUROLOGY, 2000, 44 (01) :22-30

[2]

BERGAMASCO B, 1990, ACTA NEUROL SCAND, V81, P383

[3]

Clarke CE, 2002, NEUROLOGY, V58, pA469

[4] Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial [J].

Holloway, R ;

Shoulson, I ;

Kieburtz, K ;

McDermott, M ;

Tariot, P ;

Kamp, C ;

Day, D ;

Shinaman, A ;

Fahn, S ;

Lang, A ;

Marek, K ;

Seibyl, J ;

Weiner, W ;

Welsh, M ;

Pahwa, R ;

Coe, S ;

Barclay, L ;

Sutherland, L ;

Hildebrand, K ;

Hubble, J ;

Weeks, C ;

LeWitt, P ;

Miyasaki, J ;

Duff, J ;

Sime, E ;

Suchowersky, O ;

Stacy, M ;

Kurth, M ;

Brewer, M ;

Harrigan, M ;

Russell, DS ;

Fussell, B ;

Ford, B ;

Dillon, S ;

Hammerstad, J ;

Stone, C ;

Riley, D ;

Rainey, P ;

Standaert, D ;

Tennis, M ;

Wooten, F ;

Rost-Ruffner, E ;

Factor, S ;

Brown, D ;

Jankovic, J ;

Atassi, F ;

Kurlan, R ;

Gardiner, I ;

Panisset, M ;

Amyot, D .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15) :1931-1938

[5]

Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653

[6]

Morrish PK, 2002, JAMA-J AM MED ASSOC, V288, P312

[7]

OERTEL WH, 2000, MOV DISORD S3, V5, P4

[8]

*PARK STUD GROUP, 2002, NEUROLOGY S3, V58, pA81

[9]

RAMAKER C, 2000, COCHRANE DB SYST REV, P2258

[10] A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa [J].

Rascol, O ;

Brooks, DJ ;

Korczyn, AD ;

De Deyn, PP ;

Clarke, CE ;

Lang, AE .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1484-1491

← 1 2 →